| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 274.34 | 0.1% |
| Total Income | 274.94 | 0.3% |
| Expenditure | 298.96 | 2.6% |
| PBT | -24.02 | 26.9% |
| Net Profit | -21.89 | 9.4% |
| OPM | 1.59% | 23.41pp |
| NPM | -7.96% | 0.86pp |
| EPS | 9.26 | 190.6% |
Best Agrolife Reduces YoY Q4 FY’25 Losses by 74%, Improves Full Year Gross Margin by 487 bps
24 May 2025 · 24 May 2025, 05:32 pm
Summary
Best Agrolife Limited, a leading agrochemicals manufacturer, announced its audited financial results for the quarter and year ended 31st March, 2025. The company reported a reduction in losses from ¥92 Cr in Q4 FY’24 to $24 Cr in Q4 FY’25 and an improvement in gross margins and reduced operating expenses. The company also strengthened its operating cash flow position and reduced total borrowings. Key strategic initiatives and product launches are expected to drive profitability and accountability across sales channels and reinforce production capabilities.
Key Highlights
- 1
Revenue for FY25 was ¥1,814.3 Cr, a 103% increase from FY24.
- 2
EBITDA for FY25 was ¥200.2 Cr, a 106% increase from FY24.
- 3
PBT for FY25 was ¥96.3 Cr, a 74% increase from FY24.
- 4
PAT for FY25 was ¥69.9 Cr, a 106% increase from FY24.
- 5
Entered into a strategic partnership with Shanghai E-Tong Chemical Co Ltd.
- 6
Launched patented herbicide ‘Shot Down’ in the Indian market.
- 7
Received registration for indigenous manufacturing of Haloxyfop-R-Methyl Ester Technical 96% w/w.
Management Comments
Mr. Vimal Kumar
We are pleased to share the improved performance in Q4 FY’25 having brought a turnaround in our financial and operational performance. Our concerted efforts towards cost optimization, strategic restructuring, and improved operational efficiency and brand business have led to a reduction in losses, from ¥92 Cr in Q4 FY’24 to $24 Cr this quarter. We believe that our improved gross margins and reduced operating expenses reflect our disciplined approach and commitment to sustainable growth.
Informational and educational content only. Not investment advice.